Schermuly, R T <br/><br/>
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.  [electronic resource] 

 -  American journal of physiology. Lung cellular and molecular physiology  Dec 2001 
 - L1361-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1040-0605 
<br/><br/><label>Standard No.: </label>10.1152/ajplung.2001.281.6.L1361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--pharmacology<br/>Administration, Inhalation<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Cyclic AMP--metabolism<br/>Dipyridamole--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Epoprostenol--pharmacology<br/>Hypertension, Pulmonary--drug therapy<br/>Nebulizers and Vaporizers<br/>Pentoxifylline--pharmacology<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Pressure<br/>Pulmonary Gas Exchange--drug effects<br/>Rabbits<br/>Theophylline--pharmacology<br/>Vasoconstrictor Agents--pharmacology<br/>Ventilation-Perfusion Ratio--drug effects